Ajanta Pharma Board to Consider Equity Dividend in Upcoming Meeting
The Board of Directors of Ajanta Pharma is scheduled to meet to consider an equity dividend. The meeting is set to take place on November 3,…
Ajanta Pharma Board to Consider Equity Dividend in Upcoming Meeting
The Board of Directors of Ajanta Pharma is scheduled to meet on November 3, 2025, to consider an equity dividend. The board will also review…
Balkrishna Industries Board to Consider Interim Dividend on October 31st
The Board of Directors of Balkrishna Industries is scheduled to meet on October 31st, 2025, to consider and approve the unaudited financial…
Colgate-Palmolive Q2 FY’26 Sales Decline Amid GST Disruptions, Interim Dividend Declared
Colgate-Palmolive (India) Limited reported a 6.3% year-over-year decline in net sales for Q2 FY’26, impacted by GST-related disruptions.…
Colgate-Palmolive Q2 FY’26 Sales Decline, Interim Dividend Declared
Colgate-Palmolive (India) Limited reported a 6.3% year-over-year decrease in net sales for Q2 FY’26, but noted a 6.1% sequential growth.…
Dabur India Interim Dividend Record Date Set for November 7, 2025
Dabur India has announced that the record date for determining shareholders’ eligibility for the interim dividend is November 7, 2025.…
RailTel Board to Consider Interim Dividend on October 29, 2025
RailTel has announced a board meeting scheduled for October 29, 2025, to consider and approve the unaudited financial results for the quarter…
Hindustan Unilever Q2 2026 Results; Interim Dividend Declared
Hindustan Unilever Limited (HUL) announced its Q2 2026 results, reporting a revenue from operations of ₹16,034 crore. The Board declared an…
Hindustan Unilever Declares Interim Dividend of ₹19 Per Share
Hindustan Unilever Limited (HUL) has announced an interim dividend of ₹19 per equity share (face value of ₹1) for the financial year ending…
Sundram Fasteners Board to Consider Unaudited Financial Results and Interim Dividend
The Board of Directors of Sundram Fasteners is scheduled to meet on October 28, 2025, to review and approve the unaudited financial results…